Oscar HealthOSCR -3.68%79 EBITDA Margin % is 15.30% as of Mar. 2026. GuruFocus rates OSCR with a GF Score™ of 79/100 and a GF Value™ of $21.04 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 18 Healthcare Plans companies, Oscar Health ranks worse than 83.33% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Oscar Health's EBITDA for the
three
months ended in Mar. 2026 was $711 Mil. Oscar Health's Revenue for the
three
months ended in Mar. 2026 was $4,647 Mil. Therefore, Oscar Health's EBITDA margin for the quarter that ended in Mar. 2026 was 15.30%.
Oscar Health (NYSE:OSCR) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Oscar Health EBITDA Margin % Related Terms
Oscar Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Oscar Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSCR vs MOH, ALHC, CLOV: EBITDA Margin % Comparison
For the Healthcare Plans subindustry, Oscar Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oscar Health EBITDA Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Oscar Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Oscar Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health (OSCR) has a EBITDA Margin % of 15.30% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Oscar Health and its competitors. According to the industry distribution chart, Oscar Health ranks #15 out of 18 companies in the Healthcare Plans industry, placing it in the top 83.3%.
Is Oscar Health's EBITDA Margin % too high?
Oscar Health's current EBITDA Margin % is 15.30%. The Healthcare Plans industry median EBITDA Margin % is 4.56. Oscar Health's value of 15.30% is 235.9% above this industry median. Based on the distribution chart, Oscar Health ranks #15 out of 18 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Oscar Health has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oscar Health's EBITDA Margin % compare to MOH and ALHC?
According to the Healthcare Plans industry distribution chart, Oscar Health ranks #15 out of 18 companies for EBITDA Margin %. This places Oscar Health in the lower half of its industry. The industry median EBITDA Margin % is 4.56. Oscar Health's value of 15.30% is 235.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Plans company?
The median EBITDA Margin % among Healthcare Plans companies is 4.56, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oscar Health's current EBITDA Margin % of 15.30% is 235.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Oscar Health and its competitors. For the Healthcare Plans industry, the median EBITDA Margin % is 4.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oscar Health's current EBITDA Margin % is 15.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oscar Health stock overvalued right now?
Based on GuruFocus' analysis, Oscar Health (OSCR) is currently considered Significantly Overvalued. The stock's GF Value™ is $21.04, compared to a current price of $28.83 — trading 37% above its estimated fair value. The current EBITDA Margin % is 15.30% and 235.9% above the Healthcare Plans industry median of 4.56. Oscar Health's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Oscar Health (OSCR), the current EBITDA Margin % is 15.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oscar Health (OSCR) Overvalued in 2026?
Based on GuruFocus' analysis, Oscar Health stock appears to be overvalued.
The current stock price of $28.83 is trading 37% above its estimated GF Value™ of $21.04.
GuruFocus considers Oscar Health to be Significantly Overvalued.
Key valuation signals for OSCR:
EBITDA Margin %: 15.30%
GF Value™: $21.04 vs. price of $28.83 (37% above fair value)
Industry Position: 235.9% above the Healthcare Plans median (#15 of 18)
No single metric tells the full story. See the OSCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
79GF Score
Get the complete analysis for OSCR
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSCR has been successfully added to your 
